The $1 Trillion Buyback Boom, Who’s Spending Most to Boost Their Stock?
In February 2025 alone, corporate America saw an explosion of stock buybacks. More than 160 companies announced fresh repurchase plans—more than double the previous month’s tally. But the real story isn’t just the sheer volume; it’s who is leading the charge.
Goldman Sachs projects that S&P 500 buybacks will hit a record-breaking $1 trillion in 2025,
» Read more about: The $1 Trillion Buyback Boom, Who’s Spending Most to Boost Their Stock? »
Read More
The Single Best ETF to Buy for 2024?
By many measures, the stock market is overextended now yet calls for a correction have vanished with the wind in recent weeks.
Within a few weeks, though, we expect the market will find a plateau and turnaround. If it does top as expected and start a new downtrend, one index above all others could be the top performer in 2024.
» Read more about: The Single Best ETF to Buy for 2024? »
Read More
What To Do When It Hits The Fan
When markets fall, they seem to go down in sync. It’s one of the key insights into markets that many ordinary investors fail to spot, the correlation between markets.
Similarly, this year you’ll see the S&P 500 up 25%, and the NASDAQ up closer to 45%, and the Dow Jones Industrial Average up too.
» Read more about: What To Do When It Hits The Fan »
Read More
1 Overlooked Stock with Huge Potential
A couple of decades ago, eBay stock was all the rage. Buyers and sellers couldn’t get enough of the platform, transacting in a wide range of goods, and investors couldn’t get enough of the stock. When PayPal was spun out, eBay became a whole lot less interesting to investors, and today it stands virtually ignored.
» Read more about: 1 Overlooked Stock with Huge Potential »
Read More
Is This Cathie Wood Stock The Next Big Thing?
Tempus AI (NASDAQ:TEM) has seen its stock run all over the board since its IPO last year. The 52-week range for TEM shares runs from a low of $22.89 to a high of $91.45. This is perhaps unsurprising because Tempus is a young, innovative AI startup.
Since the start of 2025,
» Read more about: Is This Cathie Wood Stock The Next Big Thing? »
Read MoreThe Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Spotlight
Spotlight: What to Buy If Things Get Crazy Soon
Among the first lessons any great investor learns is “Don’t Fight The Fed.” Simply put, it means when the Fed is accommodative and engaging in quantitative easing, money is cheap and economies boom. Some call this the Fed Put because as markets fall, the Federal Reserve acts swiftly to provide liquid support by buying bonds.
» Read more about: Spotlight: What to Buy If Things Get Crazy Soon »
Read MoreThe Daily
Stock Market Today: S&P 500 Futures Rise After Snapping A 7-Day Streak—Nuburu, AZZ, Joby Aviation In Focus
U.S. stock futures rose on Wednesday following Tuesday’s declines. Futures of major benchmark indices were higher.
Shares of Oracle Corp. (NASDAQ:ORCL) fell 2.5% on Tuesday, dragging other tech stocks after the company said that it faced financial struggles related to renting out Nvidia Corp.